Abstract
Although the literature offers a number of clinical and radiologic approaches to the investigation of reversible cerebral vasoconstriction syndrome (RCVS), clinicians faced with new presentations of intracranial arteriopathy have no validated approach to assist them.1,2 The diagnostic criteria in the International Classification of Headache Disorders, 3rd edition (ICHD-3), provides a predominantly descriptive classification of RCVS categorizing definite and probable cases3 that provides little guidance in the setting of a new acute presentation. Distinguishing between RCVS and non-RCVS arteriopathies has important management implications particularly because steroids, often used in the management of non-RCVS arteriopathies, worsen the course and outcome of RCVS.4
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
